AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9585270 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 30
Study 9585270 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol IV infusion
Number of subjects: 30
Study 7618427 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg tramadol
Number of subjects: 160
Study 7618427 — intervention group
Group type: COMPARATOR
Intervention: 50 mg pentazocine
Number of subjects: 160
Study 2729164 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure beta-carotene (12 or 30 mg)
Number of subjects: 30
Study 2729164 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrots (270 g)
Number of subjects: 30
Study 2729164 — intervention group
Group type: COMPARATOR
Intervention: Broccoli (600 g)
Number of subjects: 30
Study 2729164 — intervention group
Group type: COMPARATOR
Intervention: Tomato juice (180 g)
Number of subjects: 30
Study 665561 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg formula diet with higher protein level (0.6 g/kg)
Number of subjects: 0
Study 665561 — intervention group
Group type: EXPERIMENTAL
Intervention: Egg formula diet with oat bran
Number of subjects: 0
Study 665561 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural Guatemalan diet (0.0875 g protein/kg)
Number of subjects: 0
Study 665561 — intervention group
Group type: COMPARATOR
Intervention: Recommended dietary allowances of protein
Number of subjects: 0
Study 30650565 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 406
Study 28267945 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal intubation simulator with anatomical modifications
Number of subjects: 130
Study 28267945 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice group
Number of subjects: 130
Study 28267945 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate group
Number of subjects: 130
Study 28267945 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert group
Number of subjects: 130
Study 25605690 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice rest and supplemental text‐to‐speech communication
Number of subjects: 37
Study 25605690 — intervention group
Group type: COMPARATOR
Intervention: Voice rest alone
Number of subjects: 37
Study 24089589 — intervention group
Group type: COMPARATOR
Intervention: Strength Training + Placebo
Number of subjects: 54
Study 24089589 — intervention group
Group type: COMPARATOR
Intervention: Testosterone Treatment (TT)
Number of subjects: 54
Study 24089589 — intervention group
Group type: COMPARATOR
Intervention: Strength Training + Testosterone Treatment (ST + TT)
Number of subjects: 54
Study 21839579 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and paclitaxel (GP)
Number of subjects: 102
Study 19250103 — intervention group
Group type: EXPERIMENTAL
Intervention: New pacing mode algorithm designed to minimize right ventricular (V) pacing
Number of subjects: 208
Study 19250103 — intervention group
Group type: COMPARATOR
Intervention: DDD mode with a long atrioventricular (AV) delay
Number of subjects: 208
Study 15841789 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering treatment
Number of subjects: 55
Study 15841789 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral information
Number of subjects: 55
Study 15841789 — intervention group
Group type: EXPERIMENTAL
Intervention: Written and oral information
Number of subjects: 55
Study 11271868 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 160
Study 11271868 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 160
Study 9924533 — intervention group
Group type: EXPERIMENTAL
Intervention: Single infusion of 5 mg/kg ABLC (Group A)
Number of subjects: 77
Study 9924533 — intervention group
Group type: EXPERIMENTAL
Intervention: Two infusions of 5 mg/kg ABLC given 5 days apart (Group B)
Number of subjects: 77
Study 9924533 — intervention group
Group type: EXPERIMENTAL
Intervention: Two infusions of 5 mg/kg ABLC on consecutive days (Group C)
Number of subjects: 77
Study 9924533 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose ABLC (10-15 mg/kg.day) for treatment failures
Number of subjects: 77
Study 9924533 — intervention group
Group type: COMPARATOR
Intervention: Short-course ABLC (1-5 days)
Number of subjects: 77
Study 9924533 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B (0.75-1.0 mg/kg on alternate days over 30-34 days)
Number of subjects: 77
Study 30306284 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen at 7 L/min
Number of subjects: 98
Study 30306284 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen at 12 L/min
Number of subjects: 98
Study 28073680 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous initiation of Vitamin B12 and Folate supplementation (within 24 hours of chemotherapy initiation)
Number of subjects: 0
Study 28073680 — intervention group
Group type: COMPARATOR
Intervention: Delayed initiation of Vitamin B12 and Folate supplementation (after 5-7 days of supplementation)
Number of subjects: 0
Study 26196407 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB/TZ combination therapy
Number of subjects: 87
Study 26196407 — intervention group
Group type: COMPARATOR
Intervention: ARB/CCB combination therapy
Number of subjects: 87
Study 24190245 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline
Number of subjects: 34
Study 24190245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 19194957 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural management equipment used at recommended and moderate levels
Number of subjects: 39
Study 19194957 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural management equipment
Number of subjects: 39
Study 17307706 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs (sertraline, citalopram, paroxetine)
Number of subjects: 0
Study 17307706 — intervention group
Group type: EXPERIMENTAL
Intervention: GABAergic agents (vigabatrin, tiagabine, topiramate, phenobarbitone)
Number of subjects: 0
Study 17307706 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 15466722 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone graft
Number of subjects: 120
Study 15466722 — intervention group
Group type: COMPARATOR
Intervention: Doubled hamstring tendon graft
Number of subjects: 120
Study 12365906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% bimatoprost QD
Number of subjects: 1198
Study 12365906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% bimatoprost BID
Number of subjects: 1198
Study 12365906 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol BID
Number of subjects: 1198
Study 9681342 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon gamma, 50 microg/m2, daily subcutaneous injection
Number of subjects: 24
Study 8595638 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg BID
Number of subjects: 360
Study 8595638 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 500 mg TID
Number of subjects: 360
Study 2548018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial cells from smokers after 15 minutes of collagenase exposure (group A)
Number of subjects: 39
Study 2548018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial cells from smokers after 7 minutes of collagenase exposure (group B)
Number of subjects: 39
Study 2548018 — intervention group
Group type: COMPARATOR
Intervention: Endothelial cells from nonsmokers (group A)
Number of subjects: 39
Study 2548018 — intervention group
Group type: COMPARATOR
Intervention: Endothelial cells from nonsmokers (group B)
Number of subjects: 39
Study 2548018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial cells from smokers (group A)
Number of subjects: 39
Study 2548018 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelial cells from smokers (group B)
Number of subjects: 39
Study 322491 — intervention group
Group type: COMPARATOR
Intervention: naproxen sodium (550 mg initial dose followed by 275 mg every six hours for a maximum of five days)
Number of subjects: 43
Study 322491 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 43
Study 30898801 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced LiFE (eLiFE) via smartphone application
Number of subjects: 180
Study 30898801 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted LiFE (aLiFE) via paper manuals
Number of subjects: 180
Study 30898801 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving international guidelines of physical activity
Number of subjects: 180
Study 28924143 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructooligosaccharides (FOS) 16g/day for 14 days
Number of subjects: 35
Study 28924143 — intervention group
Group type: EXPERIMENTAL
Intervention: Galactooligosaccharides (GOS) 16g/day for 14 days
Number of subjects: 35
Study 25467017 — intervention group
Group type: EXPERIMENTAL
Intervention: Imetelstat (9.4 mg/kg on days 1 and 8 of a 21-day cycle)
Number of subjects: 116
Study 25467017 — intervention group
Group type: COMPARATOR
Intervention: Control (observation)
Number of subjects: 116
Study 25467017 — intervention group
Group type: EXPERIMENTAL
Intervention: Imetelstat
Number of subjects: 116
Study 25467017 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 116
Study 25467017 — intervention group
Group type: EXPERIMENTAL
Intervention: Imetelstat (in patients with short telomere length)
Number of subjects: 116
Study 25467017 — intervention group
Group type: EXPERIMENTAL
Intervention: Imetelstat (in patients with long telomere length)
Number of subjects: 116
Study 23892298 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative pulmonary rehabilitation programme (PRP)
Number of subjects: 40
Study 23892298 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy only (Control Group S)
Number of subjects: 40
Study 21820095 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful CTO PCI in patients with DM
Number of subjects: 1742
Study 21820095 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of drug-eluting stents (DES) in patients with DM
Number of subjects: 1742
Study 21820095 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of drug-eluting stents (DES) in patients without DM
Number of subjects: 1742
Study 21820095 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful CTO PCI in patients without DM
Number of subjects: 1742
Study 19428082 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing at the prostatic vesical junction (group 1)
Number of subjects: 156
Study 19428082 — intervention group
Group type: EXPERIMENTAL
Intervention: Urethral catheter traction (group 2)
Number of subjects: 156
Study 17527093 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleoside-sparing regimen (lopinavir/ritonavir at 533/133 mg twice a day and efavirenz at 600 mg/d)
Number of subjects: 62
Study 17527093 — intervention group
Group type: COMPARATOR
Intervention: Nucleoside-containing regimen (efavirenz and 2 nucleoside analogues)
Number of subjects: 62
Study 17527093 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz)
Number of subjects: 62
Study 15103923 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with 5-ml dose of 1% lidocaine injected into the periprostatic nerve plexus at 3 minutes before the procedure
Number of subjects: 178
Study 15103923 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia (control group)
Number of subjects: 178
Study 15103923 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with 5-ml dose of 1% lidocaine
Number of subjects: 178
Study 11473488 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (Ex)
Number of subjects: 80
Study 11473488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 80
Study 11473488 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Hormone Replacement Therapy (ExHRT)
Number of subjects: 80
Study 11473488 — intervention group
Group type: COMPARATOR
Intervention: Control (Co)
Number of subjects: 80
Study 9711449 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg/day
Number of subjects: 0
Study 9711449 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 5 mg/day
Number of subjects: 0
Study 9711449 — intervention group
Group type: COMPARATOR
Intervention: Montelukast
Number of subjects: 0
Study 7852181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography
Number of subjects: 950
Study 7852181 — intervention group
Group type: COMPARATOR
Intervention: Physical examination
Number of subjects: 950
Study 3289850 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45 (10 mg infusion for at least 3 days before operation)
Number of subjects: 100
Study 3289850 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 100
Study 3289850 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45
Number of subjects: 100
Study 30221841 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-to-target (TTT) intervention
Number of subjects: 321
Study 27737930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu AF09535
Number of subjects: 0
Study 25548845 — intervention group
Group type: EXPERIMENTAL
Intervention: RT002 (injectable botulinum toxin type A)
Number of subjects: 48
Study 23347858 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with bare-metal stents
Number of subjects: 220
Study 23347858 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive direct coronary artery bypass surgery (MIDCAB)
Number of subjects: 220
Study 21315003 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP) with continuous veno-venous hemofiltration (CVVH) for 72 hours, ultrafiltrate volume 40 ml×kg(‐1)×h(‐1)
Number of subjects: 45
Study 21315003 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment according to international guidelines)
Number of subjects: 45
Study 19720365 — intervention group
Group type: EXPERIMENTAL
Intervention: Live oral cholera vaccine 638 (2 x 10(9) CFU)
Number of subjects: 36
Study 19720365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 18071169 — intervention group
Group type: EXPERIMENTAL
Intervention: Levomethadyl
Number of subjects: 165
Study 18071169 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 165
Study 18071169 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine
Number of subjects: 165
Study 15376518 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-microA, 20-s current pulses through deionized water
Number of subjects: 0
Study 15376518 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-microA, 20-s current pulses through saturated 20.4% NaCl solution
Number of subjects: 0
Study 15376518 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-microA, 20-s current pulses through 1% acetylcholine
Number of subjects: 0
Study 15376518 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-microA, 20-s current pulses through 1% sodium nitroprusside
Number of subjects: 0
Study 11575110 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR and antibiotics (minocycline ointment locally, doxycycline and amoxyline systemically)
Number of subjects: 20
Study 11575110 — intervention group
Group type: COMPARATOR
Intervention: GTR alone (control group)
Number of subjects: 20
Study 9606770 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-hospital rehabilitation (DHR)
Number of subjects: 15
Study 9606770 — intervention group
Group type: COMPARATOR
Intervention: Control group (varied definitions)
Number of subjects: 15
Study 7992907 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 0 micrograms.kg‐1
Number of subjects: 120
Study 7992907 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms.kg‐1
Number of subjects: 120
Study 7992907 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 4 micrograms.kg‐1
Number of subjects: 120
Study 2563454 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced hypoxic-reperfusion injury
Number of subjects: 0
Study 9297 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine
Number of subjects: 19
Study 9297 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 19
Study 9297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 30882524 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural boluses (6-mL every 45 minutes with 0.1% ropivacaine and 2 microg/mL fentanyl)
Number of subjects: 120
Study 30882524 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (8 mL/h with 0.1% ropivacaine and 2 microg/mL fentanyl)
Number of subjects: 120
Study 30882524 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed intermittent epidural boluses
Number of subjects: 120
Study 30882524 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion
Number of subjects: 120
Study 31641199 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibrated interdental brushes (IDBs) used daily on test sites.
Number of subjects: 25
Study 31641199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cleaning on control sites).
Number of subjects: 25
Study 30569677 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive osteotomy Ilizarov technique combined with intramedullary nail
Number of subjects: 71
Study 30569677 — intervention group
Group type: COMPARATOR
Intervention: Simple Ilizarov technique
Number of subjects: 71
Study 27241876 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine consultations
Number of subjects: 402
Study 27241876 — intervention group
Group type: COMPARATOR
Intervention: Traditional specialist consultations
Number of subjects: 402
Study 24717389 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care in the ZODIAC trial
Number of subjects: 18154
Study 24717389 — intervention group
Group type: EXPERIMENTAL
Intervention: History of suicide attempts
Number of subjects: 18154
Study 24717389 — intervention group
Group type: EXPERIMENTAL
Intervention: Usage of antidepressant medication
Number of subjects: 18154
Study 24717389 — intervention group
Group type: EXPERIMENTAL
Intervention: History of > 5 hospitalizations in the past
Number of subjects: 18154
Study 22515941 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fat diet (20% total energy from long chain triglycerides)
Number of subjects: 117
Study 22515941 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fat diet (20% from long chain triglycerides and 20% from medium chain triglycerides)
Number of subjects: 117
Study 22515941 — intervention group
Group type: COMPARATOR
Intervention: Normal fat diet (40% total energy from long chain triglycerides)
Number of subjects: 117
Study 20574943 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent graft
Number of subjects: 0
Study 20574943 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTA)
Number of subjects: 0
Study 17615257 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFB1 gene polymorphisms (specifically high TGFB1 producer genotypes, ‐509TT and 10Pro/Pro)
Number of subjects: 754
Study 17615257 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFB1 gene polymorphisms (specifically ‐509TT)
Number of subjects: 754
Study 17615257 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis under a recessive model
Number of subjects: 754
Study 17615257 — intervention group
Group type: COMPARATOR
Intervention: Polymorphisms at codons 25 and 263
Number of subjects: 754
Study 16131584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (physical activity-behavior-diet-based) for 3 months
Number of subjects: 21
Study 16131584 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched lean adolescents)
Number of subjects: 21
Study 11999260 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention for hazardous alcohol use
Number of subjects: 16
Study 10606193 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 650
Study 7575696 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of rheumatoid factor
Number of subjects: 1
Study 7575696 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of damage at baseline
Number of subjects: 1
Study 7575696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative joint inflammation
Number of subjects: 1
Study 7575696 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued joint inflammation
Number of subjects: 1
Study 2405609 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and dipyridamole
Number of subjects: 243
Study 2405609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 7363436 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide (200 mg single dose)
Number of subjects: 16
Study 7363436 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg single dose)
Number of subjects: 16
Study 7363436 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic disopyramide therapy (200 mg every 6 hours for 1 week)
Number of subjects: 16
Study 7363436 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic propranolol therapy (80 mg every 8 hours for 1 week)
Number of subjects: 16
Study 7363436 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent administration of propranolol and disopyramide
Number of subjects: 16
Study 31299857 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP27 (10 picomol/kg/min)
Number of subjects: 20
Study 31299857 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 20
Study 31299857 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP27
Number of subjects: 20
Study 31319363 — intervention group
Group type: EXPERIMENTAL
Intervention: Identifying one target in simulated traffic scenes
Number of subjects: 79
Study 31319363 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit instructions regarding the level of risk in Experiment 2
Number of subjects: 79
Study 28723718 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD group (head-mounted device-based gaming procedure)
Number of subjects: 47
Study 28723718 — intervention group
Group type: EXPERIMENTAL
Intervention: HMD group
Number of subjects: 47
Study 28723718 — intervention group
Group type: COMPARATOR
Intervention: Control group (vestibular rehabilitation only)
Number of subjects: 47
Study 25498130 — intervention group
Group type: EXPERIMENTAL
Intervention: IDegAsp
Number of subjects: 424